Novartis Access defined

Novartis Access is a Group-wide initiative that supports expanded access to our medicines in low- and lower-middle income countries. The Novartis Access program focuses on affordability and availability of 15 on- and off-patent medicines addressing key noncommunicable diseases (NCDs) – cardiovascular diseases, diabetes, respiratory illnesses, and breast cancer. The portfolio is offered as a basket to governments, non-governmental organizations (NGOs) and other public-sector customers at a price of USD 1 per treatment per month. Built as a social business, the program aims to become commercially sustainable in the next 5-10 years.

Novartis Access is integrated in Novartis Social Business, a unit that includes the Novartis Malaria Initiative and the Novartis Healthy Family programs. This unit is operationally managed by Sandoz, the Novartis generics and biosimilars division.

To learn more visit: http://socialbusiness.novartis.com